Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 14
2018 76
2019 71
2020 105
2021 88
2022 67
2023 67
2024 51
2025 62
2026 16

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

501 results

Results by year

Filters applied: . Clear all
Page 1
2024 National Clinical Database annual report by the Japan surgical society.
Yamamoto T, Takahashi A, Yoshizumi T, Ishihara S, Inomata M, Imoto S, Eguchi H, Ebata T, Otsuka M, Okuyama H, Kakeji Y, Kato T, Kamei T, Saiki Y, Saito A, Shimizu H, Soga Y, Tajiri T, Nogi H, Hatano E, Hara H, Bitoh Y, Mizushima T, Minatoya K, Miyagawa S, Yamauchi H, Yoshino I, Baba H, Matsubara H, Ohki T, Hasegawa K, Taketomi A. Yamamoto T, et al. Among authors: ebata t. Surg Today. 2026 Apr 7. doi: 10.1007/s00595-026-03266-4. Online ahead of print. Surg Today. 2026. PMID: 41946904 No abstract available.
Impact of prior immune checkpoint inhibitor on trastuzumab deruxtecan in HER2-positive advanced gastric cancer: exploratory analysis of the EN-DEAVOR study.
Narita Y, Kawakami H, Nakanishi K, Makiyama A, Sugimoto N, Konishi H, Morita S, Minashi K, Imano M, Inamoto R, Nishina T, Kawakami T, Hagiwara M, Kodera Y, Kume H, Yamaguchi K, Hashimoto W, Muro K. Narita Y, et al. Among authors: kodera y. Jpn J Clin Oncol. 2026 Mar 6:hyaf216. doi: 10.1093/jjco/hyaf216. Online ahead of print. Jpn J Clin Oncol. 2026. PMID: 41789591
Phase II study of FOLFIRI with low-dose irinotecan plus ramucirumab as second-line treatment in Japanese patients with metastatic colorectal cancer (study rindo).
Hattori N, Nakayama G, Umeda S, Kishida T, Takeda S, Ezaka K, Tsutsuyama M, Sakai M, Hattori M, Ito T, Kanda M, Tanaka C, Murotani K, Ando M, Kodera Y. Hattori N, et al. Among authors: kodera y. Jpn J Clin Oncol. 2026 Mar 13;56(3):267-273. doi: 10.1093/jjco/hyaf198. Jpn J Clin Oncol. 2026. PMID: 41359440 Free PMC article. Clinical Trial.
501 results